EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Comparison of Uterine Closure Techniques and Their Association With Cesarean Scar Defect Development: A Randomized Controlled Trial

Ezgi Oktay, Hüseyin Durukan, Hakan Aytan

Clinical and Experimental Obstetrics & Gynecology · 2026-10-20 · 53 (10)

DOI: 10.31083/ceog52842 ↗
AbstractBibliografische Angaben

Abstract

Background: To compare three uterine closure techniques regarding postoperative residual myometrial thickness (RMT) and their association with cesarean scar defect (CSD) formation. Methods: A prospective, assessor-blinded, randomized controlled trial (RCT) was conducted in 48 nulliparous women undergoing primary cesarean delivery. Participants were randomly assigned to one of three groups: Group 1, double-layer continuous non-locking suturing with endometrial inclusion and an imbricating second layer; Group 2, double-layer continuous non-locking suturing without endometrial inclusion and an imbricating second layer; Group 3, double-layer continuous suturing with the first layer incorporating the endometrium and deep myometrium and the second layer including the remaining myometrium. Transvaginal ultrasonography was performed 6 months postoperatively to measure RMT and evaluate the presence of CSDs. The study was powered to detect differences in RMT rather than CSD incidence. Results: No significant differences in preoperative and postoperative changes in visual analog scale (VAS) scores were observed among the groups. Mean RMT was comparable across the three groups (7.1 ± 2.2 mm, 7.3 ± 1.6 mm, and 7.4 ± 1.8 mm, respectively; p = 0.920). CSD was identified in 7.1%, 21.4%, and 6.7% of patients in Groups 1, 2, and 3, respectively (overall incidence, 11.6%; p = 0.404). Conclusion: No significant differences in postoperative RMT were observed among the uterine closure techniques evaluated. Larger prospective studies powered to detect differences in CSD outcomes are warranted. Clinical Trial Registration: The study was registered to https://clinicaltrials.gov/ with an ID of NCT05100147 (https://clinicaltrials.gov/study/NCT05100147?cond=NCT05100147%20&rank=1).

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →